PARP1 and neoplasm: PARP1 inhibitors cause replication stress by inhibiting PARP1-dependent repair of single-strand damage and from PARP1-trapping on damaged DNA, accounting for the synthetic lethality of PARP1 inhibitors in HR-deficient tumor cells[35,208].